Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2020 8
2021 4
2022 2
2023 1
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.
Roddie C, Sandhu KS, Tholouli E, Logan AC, Shaughnessy P, Barba P, Ghobadi A, Guerreiro M, Yallop D, Abedi M, Pantin JM, Yared JA, Beitinjaneh AM, Chaganti S, Hodby K, Menne T, Arellano ML, Malladi R, Shah BD, Mountjoy L, O'Dwyer KM, Peggs KS, Lao-Sirieix P, Zhang Y, Brugger W, Braendle E, Pule M, Bishop MR, DeAngelo DJ, Park JH, Jabbour E. Roddie C, et al. Among authors: mountjoy l. N Engl J Med. 2024 Dec 12;391(23):2219-2230. doi: 10.1056/NEJMoa2406526. Epub 2024 Nov 27. N Engl J Med. 2024. PMID: 39602653 Clinical Trial.
Glucagonoma-Associated Rash.
Mountjoy L, Kollmorgen D. Mountjoy L, et al. N Engl J Med. 2017 Mar 9;376(10):e18. doi: 10.1056/NEJMicm1603135. N Engl J Med. 2017. PMID: 28273025 Free article. No abstract available.
Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze KL, Golafshar M, Uson PLS Jr, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez EA, Lizaola-Mayo B, Lehrer M, Thorpe CS, Yu NY, Esplin ED, Nussbaum RL, Sharp RR, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce AH, Bekaii-Saab TS, Sekulic A, Stewart AK. Samadder NJ, et al. Among authors: mountjoy l. JAMA Oncol. 2021 Feb 1;7(2):230-237. doi: 10.1001/jamaoncol.2020.6252. JAMA Oncol. 2021. PMID: 33126242 Free PMC article.
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.
Roloff GW, Aldoss I, Kopmar NE, Lin C, Dekker SE, Gupta VK, O'Connor TE, Jeyakumar N, Muhsen IN, Valtis Y, Ahmed N, Zhang A, Miller K, Dykes KC, Ahmed M, Chen EC, Mercadal S, Schwartz M, Tracy SI, Dholaria B, Mukherjee A, Battiwalla M, Logan AC, Ladha A, Guzowski C, Hoeg RT, Hilal T, Moore J, Connor MP, Hill LC, Tsai SB, Sasine JP, Solh MM, Kota VK, Koura D, Veeraputhiran M, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Pullarkat V, Stock W, Cassaday RD, Shah BD, Faramand R, Muffly L; ROCCA Consortium. Roloff GW, et al. J Clin Oncol. 2025 Feb 10;43(5):558-566. doi: 10.1200/JCO.24.00321. Epub 2024 Oct 17. J Clin Oncol. 2025. PMID: 39418622
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.
Aldoss I, Roloff GW, Faramand R, Kopmar NE, Lin C, Advani AS, Dekker SE, Gupta VK, O'Connor TE, Jeyakumar N, Muhsen IN, Valtis Y, Zhang A, Miller K, Sutherland K, Dykes KC, Ahmed M, Chen E, Zambrano H, Bradshaw D, Mercadal S, Schwartz M, Tracy S, Dholaria B, Kubiak M, Mukherjee A, Majhail N, Battiwalla M, Mountjoy L, Malik SA, Mathews J, Shaughnessy P, Logan AC, Ladha A, Stefan M, Guzowski C, Hoeg RT, Hilal T, Moore J, Connor M, O'Dwyer KM, Hill LC, Tsai SB, Sasine J, Solh MM, Lee CJ, Kota VK, Koura D, Veeraputhiran M, Blunk B, Oliai C, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Bishop MR, Stock W, Cassaday RD, Pullarkat V, Shah BD, Muffly LS. Aldoss I, et al. Among authors: mountjoy l. Blood Adv. 2024 Dec 10;8(23):6139-6147. doi: 10.1182/bloodadvances.2024013747. Blood Adv. 2024. PMID: 39093952 Free PMC article.
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.
Muhsen IN, Roloff GW, Faramand R, Othman T, Valtis Y, Kopmar NE, Dekker SE, Connor M, Mercadal S, O'Connor TE, Dykes KC, Ahmed M, Jeyakumar N, Zhang A, Miller K, Sutherland KC, Guzowski C, Gupta VK, Majhail N, Battiwalla M, Solh MM, Malik SA, Mathews J, Oliai CH, Shaughnessy P, Mountjoy L, Lee CJ, Logan AC, Tsai SB, Leonard JT, Schwartz M, Sasine JP, Kumaran M, Frey N, Park JH, Koura D, Cassaday RD, Shah BD, Aldoss I, Muffly LS, Hill LC. Muhsen IN, et al. Among authors: mountjoy l. Blood Adv. 2025 Aug 26;9(16):4081-4089. doi: 10.1182/bloodadvances.2024015779. Blood Adv. 2025. PMID: 40334068 Free PMC article.
Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in Lymphoma.
Rao UK, Majhail NS, Blunk B, Abernathy K, Bachier C, Bhushan V, Cruz JC, Elayan M, Gregory T, LeMaistre CF, Malik SA, Martin C, Mattlin M, Blade G, Maris MB, Mathews J, Mountjoy L, Pantin JM, Ramakrishnan A, Shaughnessy P, Tees MT, Vance EA, Zoghi B, Battiwalla M. Rao UK, et al. Among authors: mountjoy l. Transplant Cell Ther. 2025 Aug;31(8):549.e1-549.e11. doi: 10.1016/j.jtct.2025.03.012. Epub 2025 Mar 22. Transplant Cell Ther. 2025. PMID: 40122282
Atrio-Esophageal Fistula: A Case Series and Literature Review.
Schuring CA, Mountjoy LJ, Priaulx AB, Schneider RJ, Smith HL, Wall GC, Kadaria D, Sodhi A. Schuring CA, et al. Among authors: mountjoy lj. Am J Case Rep. 2017 Aug 1;18:847-854. doi: 10.12659/ajcr.903966. Am J Case Rep. 2017. PMID: 28761039 Free PMC article. Review.
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.
Valtis YK, Lin C, Nemirovsky D, Devlin SM, Rejeski K, Curran KJ, Wang X, Shah NN, Jeyakumar N, Miller K, Zhang A, Kota VK, Al Darobi A, Muhsen IN, Sasine JP, Aldoss I, Advani AS, Reshef R, Chen EC, Kopmar NE, Tsai SB, Hilal T, Shah BD, Faramand RG, Solh MM, Tan V, Bezerra ED, Battiwalla M, Ramakrishnan A, Mathews J, Shaughnessy PJ, Mountjoy L, Hoeg RT, Dykes KC, Logan AC, Kumaran M, Schwartz MS, Tracy SI, Moore J, Odstrcil Bobillo S, Frey NV, Connor MP, Ladha A, Dholaria B, Sutherland KC, Roloff GW, Muffly LS, Park JH. Valtis YK, et al. Among authors: mountjoy l. Blood Adv. 2025 Oct 6:bloodadvances.2025017526. doi: 10.1182/bloodadvances.2025017526. Online ahead of print. Blood Adv. 2025. PMID: 41052404
21 results